The ABL and JAK Tyrosine Kinase Pathways Are Co-Activated in BCR/ABL1 Positive Acute Lymphoblastic Leukemia

被引：0

作者：

Bhagavathi, S. ^{[1
]}

Aviv, H. ^{[1
]}

机构：

[1] Rutgers State Univ, New Brunswick, NJ USA

来源：

JOURNAL OF MOLECULAR DIAGNOSTICS | 2016年 / 18卷 / 06期

关键词：

D O I：

暂无

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

H30

引用

页码：958 / 958

页数：1

共 50 条

[31] Clinical Relevance of Tyrosine Kinase Fusion Genes in Pediatric BCR-ABL1-like Acute Lymphoblastic Leukemia
Boer, Judith M.
Boeree, Aurelie
Marchante, Joao R. M.
Beverloo, Berna
Escherich, Gabriele
de Croot-Kruseman, Hester A.
Pieters, Rob
Den Boer, Monique L.
BLOOD, 2015, 126 (23)
[32] Prognostic significance of a normal karyotype in adult patients with BCR-ABL1-positive acute lymphoblastic leukemia in the tyrosine kinase inhibitor era
Shi, Ting
Wang, Huanping
Xie, Mixue
Li, Xueying
Zhu, Lixia
Ye, Xiujin
CLINICS, 2020, 75
[33] COMPARATIVE ANALYSIS OF POSITIVE AND NEGATIVE ACUTE LYMPHOBLASTIC LEUKAEMIA BCR-ABL1 IN THE ERA OF INHIBITORS OF TYROSINE KINASE
De Una Soraya, Lorente
Velasco Antonio, Jimenez
Maria Jose, Moreno
Manuel, Barrios
Joaquin, Ruiz
Ana Isabel, Heiniger
HAEMATOLOGICA, 2016, 101 : 160 - 160
[34] Tyrosine kinase inhibitors in BCR/ABL positive ALL
Lopez-Enriquez, A. T.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[35] ABL1 amplification in T-cell acute lymphoblastic leukemia
Bernasconi, P
Calatroni, S
Giardini, I
Inzoli, A
Castagnola, C
Cavigliano, PM
Rocca, B
Boni, M
Quarna, J
Zappatore, R
Caresana, M
Bianchessi, C
Pallavicini, EB
Lazzarino, M
CANCER GENETICS AND CYTOGENETICS, 2005, 162 (02) : 146 - 150
[36] Clinical characteristics of patients with central nervous system relapse in BCR-ABL1-positive acute lymphoblastic leukemia: the importance of characterizing ABL1 mutations in cerebrospinal fluid
Sanchez, Ricardo
Ayala, Rosa
Alberto Alonso, Rafael
Pilar Martinez, Maria
Ribera, Jordi
Garcia, Olga
Sanchez-Pina, Jose
Mercadal, Santiago
Montesinos, Pau
Martino, Rodrigo
Barba, Pere
Gonzalez-Campos, Jose
Barrios, Manuel
Lavilla, Esperanza
Gil, Cristina
Bernal, Teresa
Escoda, Lourdes
Abella, Eugenia
Luz Amigo, Ma
Jose Moreno, Ma
Bravo, Pilar
Guardia, Ramon
Hernandez-Rivas, Jesus-Maria
Garcia-Guinon, Antoni
Piernas, Sonia
Ribera, Jose-Maria
Martinez-Lopez, Joaquin
ANNALS OF HEMATOLOGY, 2017, 96 (07) : 1069 - 1075
[37] Clinical characteristics of patients with central nervous system relapse in BCR-ABL1-positive acute lymphoblastic leukemia: the importance of characterizing ABL1 mutations in cerebrospinal fluid
Ricardo Sanchez
Rosa Ayala
Rafael Alberto Alonso
María Pilar Martínez
Jordi Ribera
Olga García
José Sanchez-Pina
Santiago Mercadal
Pau Montesinos
Rodrigo Martino
Pere Barba
José González-Campos
Manuel Barrios
Esperanza Lavilla
Cristina Gil
Teresa Bernal
Lourdes Escoda
Eugenia Abella
Ma Luz Amigo
Ma José Moreno
Pilar Bravo
Ramón Guàrdia
Jesús-María Hernández-Rivas
Antoni García-Guiñón
Sonia Piernas
José-María Ribera
Joaquín Martínez-López
Annals of Hematology, 2017, 96 : 1069 - 1075
[38] Development of resistance to dasatinib in Bcr/Abl-positive acute lymphoblastic leukemia
Fei, F.
Stoddart, S.
Mueschen, M.
Kim, Y-M
Groffen, J.
Heisterkamp, N.
LEUKEMIA, 2010, 24 (04) : 813 - 820
[39] Development of resistance to dasatinib in Bcr/Abl-positive acute lymphoblastic leukemia
F Fei
S Stoddart
M Müschen
Y-m Kim
J Groffen
N Heisterkamp
Leukemia, 2010, 24 : 813 - 820
[40] BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros
Charles G. Mullighan
Christopher B. Miller
Ina Radtke
Letha A. Phillips
James Dalton
Jing Ma
Deborah White
Timothy P. Hughes
Michelle M. Le Beau
Ching-Hon Pui
Mary V. Relling
Sheila A. Shurtleff
James R. Downing
Nature, 2008, 453 : 110 - 114

← 1 2 3 4 5 →